Cancer Immunotherapy: Sipuleucel-T and BeyondHAMMERSTROM, Aimee E; CAULEY, Diana H; ATKINSON, Bradley J et al.Pharmacotherapy. 2011, Vol 31, Num 8, pp 813-828, issn 0277-0008, 16 p.Article

Dietary factors and risk for advanced prostate cancerGATHIRUA-MWANGI, Wambui G; JIANJUN ZHANG.European journal of cancer prevention. 2014, Vol 23, Num 2, pp 96-109, issn 0959-8278, 14 p.Article

Locally advanced prostate cancer: the role of surgical managementSTRATTON, Kelly L; CHANG, Sam S.BJU international (Papier). 2009, Vol 104, Num 4, pp 449-454, issn 1464-4096, 6 p.Article

The utility of prostate-specific antigen in the management of advanced prostate cancerCRAWFORD, E. David; BENNETT, Charles L; ANDRIOLE, Gerald L et al.BJU international (Papier). 2013, Vol 112, Num 5, pp 548-560, issn 1464-4096, 13 p.Article

Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancerLANTING LU; PETERS, Jaime; ROOME, Chris et al.BJU international (Papier). 2012, Vol 109, Num 8, pp 1183-1192, issn 1464-4096, 10 p.Article

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancerMARTINEZ-PINEIRO, Luis; SCHALKEN, Jack A; CABRI, Patrick et al.BJU international (Papier). 2014, Vol 114, Num 4, pp 608-616, issn 1464-4096, 9 p.Article

Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 TrialMOTTET, Nicolas; PENEAU, Michel; MAZERON, Jean-Jacques et al.European urology. 2012, Vol 62, Num 2, pp 213-219, issn 0302-2838, 7 p.Article

Place du bicalutamide 150 mg dans le traitement du cancer de la prostate : 3ème analyse du programme PEC (Early Prostate Cancer)FOURCADE, Richard-Olivier; RICHAUD, Pierre; COLOBY, Patrick et al.Progrès en urologie (Paris). 2007, Vol 17, Num 4, pp 891-899, issn 1166-7087, 9 p., SUP1Article

Radical prostatectomy for cT3―4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohortSCHREIBER, David; RINEER, Justin; SURA, Sonal et al.BJU international (Papier). 2011, Vol 108, Num 3, pp 360-365, issn 1464-4096, 6 p.Article

A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern JapanHACHIYA, Takahiko; AKAKURA, Koichiro; SAITO, Shiro et al.BJU international (Papier). 2005, Vol 95, Num 4, pp 534-540, issn 1464-4096, 7 p.Article

Predictors of androgen independence in metastatic prostate cancerSIM, H. G; LAU, W. K. O; CHENG, C. W. S et al.BJU international (Papier). 2004, Vol 93, Num 9, pp 1221-1224, issn 1464-4096, 4 p.Article

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer : a meta-analysis of randomized controlled trialsBOUSTEAD, Gregory; EDWARDS, Steven J.BJU international (Papier). 2007, Vol 99, Num 6, pp 1383-1389, issn 1464-4096, 7 p.Article

Side-effects of treatments for locally advanced prostate cancerO'CONNOR, Kevin M; FITZPATRICK, John M.BJU international (Papier). 2006, Vol 97, Num 1, pp 22-28, issn 1464-4096, 7 p.Article

Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancerLEIBOVICI, Dan; KAMAT, Ashish M; DO, Kim A et al.The Prostate. 2005, Vol 62, Num 1, pp 101-104, issn 0270-4137, 4 p.Article

Substance Use Disorder and its Effects on Outcomes in Men With Advanced-Stage Prostate CancerCHHATRE, Sumedha; METZGER, David S; BRUCE MALKOWICZ, S et al.Cancer. 2014, Vol 120, Num 21, pp 3338-3345, issn 0008-543X, 8 p.Article

Management of advanced prostate cancer : can we improve on androqen deprivation therapy?ANDERSON, John; ABRAHAMSSON, Per-Anders; CRAWFORD, David et al.BJU international (Papier). 2008, Vol 101, Num 12, pp 1497-1501, issn 1464-4096, 5 p.Article

Early Detection of Prostate Cancer: European Association of Urology RecommendationHEIDENREICH, Axel; ABRAHAMSSON, Per-Anders; ARTIBANI, Walter et al.European urology. 2013, Vol 64, Num 3, pp 347-354, issn 0302-2838, 8 p.Article

The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cellsALONZEAU, Jessy; ALEXANDRE, David; PFISTER, Christian et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 511-519, issn 0959-8049, 9 p.Article

Clinicopathological characteristics of androgen-dependent advanced prostate cancer patients with α₂-macroglobulin deficiencyKANOH, Yuhsaku; OHTANI, Hideki; EGAWA, Shin et al.International journal of oncology. 2012, Vol 41, Num 1, pp 39-45, issn 1019-6439, 7 p.Article

Efficacy of primary hormone therapy for localized or locally advanced prostate cancer : results of a 10-year follow-upAKAZA, Hideyuki; HOMMA, Yukio; USAMI, Michiyuki et al.BJU international (Papier). 2006, Vol 98, Num 3, pp 573-579, issn 1464-4096, 7 p.Article

Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy : a multicenter, randomized, double-blind, comparative studyARAI, Yoichi; AKAZA, Hideyuki; USAMI, Michiyuki et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 12, pp 1385-1396, issn 0171-5216, 12 p.Article